A competitive Enzyme-Linked immunosorbent assay specific for murine hepcidin-1: Correlation with hepatic mrna expression in established and novel models of dysregulated iron homeostasis

Haematologica

Volumn 100, Issue 2, 2015, Pages 167-177

  Gutschow, Patrick ^a   Schmidt, Paul J ^b   Han, Huiling ^a   Ostland, Vaughn ^a   Bartnikas, Thomas B ^c   Pettiglio, Michael A ^c   Herrera, Carolina ^c   Butler, James S ^d   Nemeth, Elizabeta ^e   Ganz, Tomas ^e   Fleming, Mark D ^b   Westerman, Mark ^a  

^a Intrinsic LifeSciences LLC   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d ALNYLAM PHARMACEUTICALS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; DRUG ADMINISTRATION; DRUG TOXICITY; HAMP1 PROTEIN, MOUSE; HEPCIDIN; IRON; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSFERRIN;

ANIMAL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BETA THALASSEMIA; BLEEDING; BLOOD ANALYSIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENETICS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; LIVER; MALE; METABOLISM; MOUSE; NONHUMAN; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; PROTEIN EXPRESSION; QUALITY CONTROL PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THALASSEMIA INTERMEDIA; TRANSGENIC MOUSE; URINALYSIS;

ADMINISTRATION AND DOSAGE; ANEMIA, IRON-DEFICIENCY; ANIMALS; BETA-THALASSEMIA; CELLS, CULTURED; CHEMICALLY INDUCED; DISEASE MODELS, ANIMAL; DRUG EFFECTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HEMOCHROMATOSIS; HEPCIDINS; HOMEOSTASIS; HUMANS; INFLAMMATION; IRON; IRON OVERLOAD; LIPOPOLYSACCHARIDES; LIVER; MALE; METABOLISM; METHODS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PATHOLOGY; PHYSIOLOGY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXICITY;

EID: 84964282416     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.116723     Document Type: Article

References (44)

1. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human pep-tide, exhibits antimicrobial activity. FEBS Lett. 2000;480(2-3):147-150.
2. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806-7810.
3. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11): 7811-7819.
4. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110(7):1037-1044.
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461-2463.
6. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-1741.
7. Donovan A, Brownlie A, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776-781.
8. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5(2):299-309.
9. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellu-lar iron metabolism. J Biol Chem. 2000;275(26):19906-19912.
10. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its inter-nalization. Science. 2004;306(5704):2090-2093.
11. Badial PR, Oliveira Filho JP, Cunha PH, et al. Identification, characterization and expression analysis of hepcidin gene in sheep. Res Vet Sci. 2011;90(3):443-450.
12. Fry MM, Liggett JL, Baek SJ. Molecular cloning and expression of canine hepcidin. Vet Clin Pathol. 2004;33(4):223-227.
13. Ilyin G, Courselaud B, Troadec MB, et al. Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload(1). FEBS Lett. 2003;542(1-3):22-26.
14. Lou DQ, Nicolas G, Lesbordes JC, et al. Functional differences between hepcidin 1 and 2 in transgenic mice. Blood. 2004;103(7):2816-2821.
15. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99(7):4596-4601.
16. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrome-try. Blood. 2007;110(3):1048-1054.
17. Tjalsma H, Laarakkers CM, van Swelm R P, et al. Mass spectrometry analysis of hep-cidin peptides in experimental mouse models. PLoS One. 2011;6(3):e16762.
18. Rojas M, Woods CR, Mora AL, Xu J, Brigham KL. Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses. Am J Physiol Lung Cell Mol Physiol. 2005;288(2):L333-341.
19. DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20(11): 1885-1900.
20. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292-4297.
21. Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One. 2008;3(7):e2706.
22. Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53(4):620-628.
23. Bernstein SE. Hereditary hypotransferrine-mia with hemosiderosis, a murine disorder resembling human atransferrinemia. J Lab Clin Med. 1987;110(6):690-705.
24. Trenor CC, 3rd, Campagna DR, Sellers VM, Andrews NC, Fleming MD. The molecular defect in hypotransferrinemic mice. Blood. 2000;96(3):1113-1118.
25. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40(5):569-571.
26. Melis MA, Cau M, Congiu R, et al. A mutation in the TMPRSS6 gene, encoding a trans-membrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica. 2008;93(10):1473-1479.
27. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088-1092.
28. Folgueras AR, de Lara FM, Pendas AM, et al. Membrane-bound serine protease matrip-tase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood. 2008;112(6):2539-2545.
29. Finberg KE, Whittlesey RL, Fleming MD,Andrews NC. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeosta-sis. Blood. 2010;115(18):3817-3826.
30. Finberg KE, Whittlesey RL, Andrews NC. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood. 2011;117(17):4590-4599.
31. Meynard D, Vaja V, Sun CC, et al. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood. 2011;118(3):747-756.
32. Bartnikas TB, Steinbicker AU, Campagna DR, et al. Identification and characterization of a novel murine allele of Tmprss6. Haematologica. 2013;98(6):854-861.
33. Schmidt PJ, Toudjarska I, Sendamarai AK, et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia. Blood. 2013;121(7):1200-1208.
34. Fleming RE, Ahmann JR, Migas MC, et al. Targeted mutagenesis of the murine trans-ferrin receptor-2 gene produces hemochro-matosis. Proc Natl Acad Sci USA. 2002;99(16):10653-10658.
35. Schmidt PJ, Fleming MD. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2. Am J Hematol. 2012;87(6):588-595.
36. Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 2008;7(3):205-214.
37. D'Alessio F, Hentze MW, Muckenthaler MU. The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. J Hepatol. 2012;57(5):1052-1060.
38. Kartikasari AE, Roelofs R, Schaeps RM, et al. Secretion of bioactive hepcidin-25 by liver cells correlates with its gene transcription and points towards synergism between iron and inflammation signaling pathways. Biochim Biophys Acta. 2008;1784(12):2029-2037.
39. Wenderfer SE, Dubinsky WP, Hernandez-Sanabria M, Braun MC. Urine proteome analysis in murine nephrotoxic serum nephritis. Am J Nephrol. 2009;30(5):450-458.
40. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730-3735.
41. Liu Q, Davidoff O, Niss K, Haase VH. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest. 2012;122(12):4635-4644.
42. Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol. 2012;96(6):692-700.
43. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-1276.
44. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest. 2005; 115(8):2187-2191.